The Lung Doc retweeted
📹 Guidelines in Focus: ERS Guidelines Director Prof. Winfried Randerath interviews @ProfJDChalmers, Chief Editor of the European Respiratory Journal and co-Chair of the ERS Clinical Practice Guideline for the Management of Adult Bronchiectasis. Watch: channel.ersnet.org/channel-3…
The Lung Doc retweeted
Myeloperoxidase is a green protein contained in neutrophils. So if the sputum is green, patients have a lot of inflammation and are at high risk of exacerbation
Simple and clinically useful!
No… Not thinking of repainting a room. One of the best biomarkers for those of us living with bronchiectasis is sputum color! Very handy to keep this chart in mind… #Bronchiectasis #sputum #Phlegm #Mucus
The Lung Doc retweeted
Indians gave Rs 4,000+cr to Turkey & Azerbaijan last year through tourism. Created jobs. Boosted their economy, hotels, weddings, flights.
Today, both stand with Pakistan after Pahalgam attack.
Plenty of beautiful places in India & the world.
Please skip these 2 places.
Jai Hind.
The Lung Doc retweeted
New Comment ahead of #WorldTBDay ⬇️
'Asymptomatic tuberculosis: undetected and underestimated, but not unimportant' hubs.li/Q03cYnVb0
The Lung Doc retweeted
🔍 New Insights on Fibrotic Interstitial Lung Disease (ILD): Dynapenia and sarcopenia were independently associated with increased mortality risk in ILD:
Dynapenia: HR 2.04 (p=0.022)
Sarcopenia: HR 1.88 (p=0.049)
onlinelibrary.wiley.com/doi/…
#ILD #Sarcopenia #Dynapenia #LungDisease
The Lung Doc retweeted
Quietly remembering over 8,000 people who died of pulmonary fibrosis in 2024, including DJ Johnnie Walker, Indian musician Zakir Hussain and patient advocate Maggie Bartlett. As the year comes to an end, our thoughts are with them and their families. @ActionPFcharity #StopPF
The Lung Doc retweeted
Short-term effects of home-based pulmonary rehabilitation during outpatient-managed exacerbations of COPD: a randomised controlled trial @filipa__machado @AldaMar27171609
thorax.bmj.com/content/early…
The Lung Doc retweeted
Patient centered WASOG 2024 for ILDs and Sarcoidosis in Agra, India to discuss ILDs advances in CTD-ILDs
Meeting colleagues all around the world and sharing ideas from fibrosis to severe asthma @DrMMukherjee
#Taj #Agra the @wasog conference in Agra has been thoroughly enjoyable. Witnessing the Taj with the rising sun - and fun banter ranging from ILD to severe asthma! Woot! @Katerin27451987
The Lung Doc retweeted
Dupilumab approved in US and China today, first biologic ever in #COPD. Truly groundbreaking moment for patients with COPD, many of whom stand to gain from this incredible advance in science. Congrats @sanofi and @Regeneron. Grateful to have been a small part of this journey!
The Lung Doc retweeted
Does bronchoalveolar lavage correlate well with radiologic features in ILD? In this real-world study from the @CARE_PF registry, nope! 🧵
journal.chestnet.org/article…
The Lung Doc retweeted
A downward trend of mortality rates in patients with IPF in the modern treatment era bit.ly/3Y1XJcb
The Lung Doc retweeted
If you were wondering how a 4L donor lung can possibly be placed through a 6cm incision: gentle pressure + suction applied to the chest can do a lot! The #lung is a tremendous organ! Robotic lung transplant = smaller incision and faster recovery #transplant @ISHLT @CedarsSinai
The Lung Doc retweeted
Delighted to share our latest work from #MTWCentre Herculean effort from huge team and a real example of improved by peer review. #ThankYou
@LancetRespirMed
pdf.sciencedirectassets.com/…
The Lung Doc retweeted
Use of inhaled treprostinil in #COPD and #PH did not result in in improved outcomes. Not so perfect results (for #COPD pts) from the PERFECT trial. bit.ly/3JALxHf
The Lung Doc retweeted
A great step for #CureIPF!!! INTEGRIS-IPF, a phase IIa #RCT suggests that Bexotegrast, an αvβ6 & αvβ1 inhibitor has safety & dose-dependent efficacy. Can't wait for Phase III results. Kudos Drs Lancaster, Flaherty, #IntegrisIPF team & @ATSBlueEditor! doi.org/10.1164/rccm.202403-…
The Lung Doc retweeted
What is Brensocatib?
Its an oral medication which blocks an enzyme called dipeptidyl peptidase-1 (DPP-1, also known as cathepsin C). In the bone marrow DPP-1 activates damaging neutrophil proteases as neutrophils are maturing and so blocking it reduces lung inflammation
The Lung Doc retweeted
We are delighted to join this campaign to raise awareness for #Sarcoidosis (pronounced SAR-coy-DOH-sis) from St.Bartholomew's Hospital (London, UK) @BartsHospital @NHSBartsHealth
Will you join us and #SaySarcoidosis too?
#SarcoidosisAwareness
@StopSarcoidosis @SarcoidosisUK – at London, England








































